Objectives:

1.be able to identify the patients who have developed cardiogenic shock who will not respond to traditional pharmacotherapy; apply the recently published data on novel mechanical cardiopulmonary support to the clinical benefit of patients; recognize that every patient may need a different pathway for support during cardiogenic shock.

2.